EP1933874A4 - Gezielte biozide - Google Patents

Gezielte biozide

Info

Publication number
EP1933874A4
EP1933874A4 EP06825629A EP06825629A EP1933874A4 EP 1933874 A4 EP1933874 A4 EP 1933874A4 EP 06825629 A EP06825629 A EP 06825629A EP 06825629 A EP06825629 A EP 06825629A EP 1933874 A4 EP1933874 A4 EP 1933874A4
Authority
EP
European Patent Office
Prior art keywords
biocides
targeted
targeted biocides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06825629A
Other languages
English (en)
French (fr)
Other versions
EP1933874A2 (de
Inventor
Michael Imboden
Michael W Riggs
Deborah Schaefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona Board of Regents of University of Arizona
ioGenetics LLC
Arizona State University ASU
Original Assignee
Arizona Board of Regents of University of Arizona
ioGenetics LLC
Arizona State University ASU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board of Regents of University of Arizona, ioGenetics LLC, Arizona State University ASU filed Critical Arizona Board of Regents of University of Arizona
Publication of EP1933874A2 publication Critical patent/EP1933874A2/de
Publication of EP1933874A4 publication Critical patent/EP1933874A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP06825629A 2005-10-11 2006-10-10 Gezielte biozide Withdrawn EP1933874A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72518005P 2005-10-11 2005-10-11
PCT/US2006/039361 WO2007047189A2 (en) 2005-10-11 2006-10-10 Targeted biocides

Publications (2)

Publication Number Publication Date
EP1933874A2 EP1933874A2 (de) 2008-06-25
EP1933874A4 true EP1933874A4 (de) 2010-03-03

Family

ID=37963026

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06825629A Withdrawn EP1933874A4 (de) 2005-10-11 2006-10-10 Gezielte biozide

Country Status (4)

Country Link
EP (1) EP1933874A4 (de)
AU (1) AU2006303998A1 (de)
CA (1) CA2625580A1 (de)
WO (1) WO2007047189A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8394379B2 (en) 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
WO2012102679A1 (en) 2011-01-24 2012-08-02 National University Of Singapore Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
CN109942693B (zh) * 2019-04-03 2020-12-25 周口师范学院 一种微小隐孢子虫的ctl表位多肽及其应用和疫苗
CN113455394B (zh) * 2021-07-23 2023-06-20 中国热带农业科学院橡胶研究所 一种规模化繁育橡胶树体胚苗的标准化生产方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006430A1 (en) * 1996-08-14 1998-02-19 The Regents Of The University Of California Vaccines, antibodies, proteins, glycoproteins, dnas and rnas for prophylaxis and treatment of cryptosporidium parvum infections
WO1998007320A1 (en) * 1996-08-23 1998-02-26 North Carolina State University NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
WO2004050846A2 (en) * 2002-12-02 2004-06-17 Biosynexus Incorporated Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
WO2004110143A2 (en) * 2003-05-15 2004-12-23 Iogenetics, Inc. Targeted biocides
WO2005040201A1 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
WO2006132665A2 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2869088A1 (en) * 2002-02-07 2003-08-14 Massachusetts Institute Of Technology Anti-pathogen treatments

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006430A1 (en) * 1996-08-14 1998-02-19 The Regents Of The University Of California Vaccines, antibodies, proteins, glycoproteins, dnas and rnas for prophylaxis and treatment of cryptosporidium parvum infections
WO1998007320A1 (en) * 1996-08-23 1998-02-26 North Carolina State University NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
WO2004050846A2 (en) * 2002-12-02 2004-06-17 Biosynexus Incorporated Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
WO2004110143A2 (en) * 2003-05-15 2004-12-23 Iogenetics, Inc. Targeted biocides
WO2005040201A1 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
WO2006132665A2 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides

Also Published As

Publication number Publication date
AU2006303998A1 (en) 2007-04-26
WO2007047189A3 (en) 2007-11-15
CA2625580A1 (en) 2007-04-26
WO2007047189A2 (en) 2007-04-26
EP1933874A2 (de) 2008-06-25

Similar Documents

Publication Publication Date Title
GB0526044D0 (en) Novel herbicides
GB0510151D0 (en) Novel herbicides
IL221326A (en) Tetrahydrobenzazepines are substituted in aryl and pyrimidinyl
SI1711057T1 (sl) Biocidi
GB0603891D0 (en) Novel herbicides
GB0625598D0 (en) Novel herbicides
ZA200800365B (en) Substituted tetrahydroqulnolines
GB2412560B (en) Decoys
EP1933874A4 (de) Gezielte biozide
GB2427174B (en) Gardening aid
GB0624961D0 (en) Novel herbicides
GB0503644D0 (en) Catstep I
AU3292P (en) DP303 Dianella prunina
AU3401P (en) Archise Arctotis fastuosa
AU3393P (en) Breakwell xTriticosecale
GB0512297D0 (en) Novel herbicides
GB0520478D0 (en) Novel herbicides
GB0515681D0 (en) Novel herbicides
GB0515680D0 (en) Novel herbicides
GB0512928D0 (en) Novel herbicides
GB0512927D0 (en) Novel herbicides
GB0502486D0 (en) Novel herbicides
GB0502487D0 (en) Novel herbicides
AU309951S (en) Horseshoe
GB0521214D0 (en) Improved cultivator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100129

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/48 20060101ALI20100125BHEP

Ipc: C07K 16/20 20060101ALI20100125BHEP

Ipc: C07K 16/12 20060101ALI20100125BHEP

Ipc: A61K 39/40 20060101AFI20070618BHEP

17Q First examination report despatched

Effective date: 20100521

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101001